Book Review: 'Innovation Breakdown' by Joseph V. Gulfo - WSJ: ".... Compare MelaFind's experience in the U.S. with its reception in Europe: MelaFind was submitted for marketing approval in Europe in May 2011. It was approved just five months later. One key reason for Europe's efficient approval process is that
European governments don't review medical devices directly. Instead they certify independent "notified bodies" that specialize and compete to review new products.
The European system works more quickly than the U.S. system, and there is no evidence that it results in reduced patient safety. Rather than tweak the current system, why doesn't the U.S. just adopt the European model and call it a day? Our health and our economy would be better off for it. Google's Sergey Brin recently said that he didn't want to be a health entrepreneur because "It's just a painful business to be in . . .
the regulatory burden in the U.S. is so high that I think it would
dissuade a lot of entrepreneurs." Mr. Brin won't find anything in Dr. Gulfo's book to persuade him otherwise. Until we get our regulatory system in order, expect a lot more Yo's and not enough life-saving innovations."
more news below